Landscapes / Companies
Eledon Pharmaceuticals
Public ELDN · United States
FollowEvery new trial, moved date and filing, and a Monday email
Drugs
1
in active trials · 2 in all
Trials
3 active
8 since 2021
Drugs1
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
CD40 ligand (CD40L) antibody |
Phase 3 | Jan 2027Phase 1/2 trial completes | |||
| Next date | Jan 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Kidney Transplant Rejection, Prevention of Rejection in Kidney Transplant | ||||
| Open drug page | |||||
SEC filings
All on SEC.govNo filings loaded yet.
About
- No active trial
- Isolated cadaveric islet cells
- Registry names
- 2 names in ClinicalTrials.gov Eledon Pharmaceuticals
Anelixis Therapeutics, LLC - Sources
- ClinicalTrials.gov updated 18 Nov 2026 · SEC filings Industry-sponsored drug trials since 2021